ANÁLISE GENÉTICA E R-ISS EM PORTADORES DE MIELOMA MÚLTIPLO CANDIDATOS A TRATAMENTO INTENSIVO: ESTUDO UNICÊNTRICO.

Autor: MG Cordeiro, MD Jacomassi, AM Leal, PBF Pinotti, EA Ramos, V Rocha, GA Martinez, EDRP Velloso

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S192-S193 (2021)

Objetivos: Realizar análise citogenética convencional e molecular de portadores de mieloma múltiplo ao diagnóstico, candidatos a tratamento intensivo, descrever suas características clínicas, laboratoriais e estratificá-los de acordo com R-ISS

Externí odkaz: https://doaj.org/article/5595b5d27fa544fd9cb6dc7c7bc941ca

AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: EXPERIENCE OF A PUBLIC CENTER IN BRAZIL

Autor: L Oliveira, MD Jacomassi, LJ Otuyama, BDGC Moraes, GA Martinez, L Mariano, V Rocha

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S249- (2021)

Introduction: Several novel therapies have been developed in recent years improving multiple myeloma (MM) treatment, although autologous hematopoietic stem cell transplantation (HSCT) remains a fundamental strategy in eligible patients. HSCT is even

Externí odkaz: https://doaj.org/article/032ab818f0b3435e955b1fff621d0c4c

AGE 75 YEARS, CLINICAL STAGE III/IV, NEUTROPHILIA AND HIGH LYMPHOCYTE/MONOCYTE RATIO PREDICT DECREASED OVERALL SURVIVAL IN ELDERLY PATIENTS WITH DLBCL, NOS OLDER THAN 70 YEARS

Autor: LAPC Lage, RN Vita, LBO Alves, MD Jacomassi, HF Culler, CO Reichert, RO Costa, SAC Siqueira, V Rocha, J Pereira

Publikováno v: Hematology, Transfusion and Cell Therapy. 44:S97-S98

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3051df7c8b2d647296fe6a870005c89f
https://doi.org/10.1016/j.htct.2022.09.163

The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?

Autor: de Pádua Covas Lage LA; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo (FM-USP), São Paulo, Brazil. luis.lage@hc.fm.usp.br.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), University of São Paulo (USP), Cerqueira César, Avenue Dr. Enéas de Carvalho Aguiar, 155 - Ambulatory building - 1st. Floor, Room 61, São Paulo (SP), 05403-000, Brazil. luis.lage@hc.fm.usp.br., Araújo Soares V; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo (FM-USP), São Paulo, Brazil., Meneguin TD; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo (FM-USP), São Paulo, Brazil., Culler HF; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo (FM-USP), São Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), University of São Paulo (USP), Cerqueira César, Avenue Dr. Enéas de Carvalho Aguiar, 155 - Ambulatory building - 1st. Floor, Room 61, São Paulo (SP), 05403-000, Brazil., Reichert CO; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo (FM-USP), São Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), University of São Paulo (USP), Cerqueira César, Avenue Dr. Enéas de Carvalho Aguiar, 155 - Ambulatory building - 1st. Floor, Room 61, São Paulo (SP), 05403-000, Brazil., Jacomassi MD; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo (FM-USP), São Paulo, Brazil., Reis DGC; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo (FM-USP), São Paulo, Brazil., Zerbini MCN; Department of Pathology, Faculty of Medicine, University of São Paulo (FM-USP), São Paulo, Brazil., de Oliveira Costa R; Department of Hematology and Hemotherapy, Faculty of Medical Sciences Santos (FCMS), Centro Universitário Lusíadas (Unilus), Santos, Brazil., Rocha V; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo (FM-USP), São Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), University of São Paulo (USP), Cerqueira César, Avenue Dr. Enéas de Carvalho Aguiar, 155 - Ambulatory building - 1st. Floor, Room 61, São Paulo (SP), 05403-000, Brazil.; Fundação Pró-Sangue, Blood Bank of São Paulo, São Paulo, Brazil.; Churchill Hospital, Oxford University, Oxford, UK., Pereira J; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo (FM-USP), São Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), University of São Paulo (USP), Cerqueira César, Avenue Dr. Enéas de Carvalho Aguiar, 155 - Ambulatory building - 1st. Floor, Room 61, São Paulo (SP), 05403-000, Brazil.; Hospital Alemão Osvaldo Cruz, São Paulo, Brazil.

Publikováno v: Radiation oncology (London, England) [Radiat Oncol] 2022 Oct 22; Vol. 17 (1), pp. 171. Date of Electronic Publication: 2022 Oct 22.